Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
This Perspective suggests a characterization cascade for nanoparticle-based vaccines that takes into consideration the complexity of the materials and of their immunomodulatory responses, providing a roadmap for the preclinical validation of potential vaccine candidates.
